Cancer · 2011 · 21 citations · 43 references
Life SciencesMolecular BiologyOncologyCell AdhesionMolecular OncologyProteomicsAdhesion MoleculesCancer BiomarkersCancer ProteomicsCell-matrix AdhesionMalignant NeoplasmsOvarian CancerAdhesion Molecule BiomarkersCell Adhesion Molecule ClusteringCell Adhesion ProteinsOvarian Cancer BiomarkersOvarian Cancer Prognostic BiomarkersOvarian Tumor BiomarkersPrognostic Signature DevelopmentProtein Expression Biomarkers
BACKGROUND: Ovarian cancer cells in malignant effusions lack attachment to solid-phase matrix substrata and receive survival stimuli through cell-cell and cell-soluble matrix molecule interactions. We hypothesized that adhesion-related survival and proliferation pathway signals can inform clinical outcomes and guide targeted therapeutics. METHODS: Lysed cell pellets from a blinded set of benign (n = 20) and malignant (n = 51) peritoneal and pleural ovarian cancer patient effusions were applied to reverse-phase protein arrays and examined using validated antibodies to adhesion-associated protein endpoints. Results were subjected to hierarchical clustering for signature development. Association between specimen type, protein expression, and clinicopathologic associations were analyzed using the Mann-Whitney U test. Survival outcomes were estimated using the Kaplan-Meier method with log-rank comparison. RESULTS: A cell adhesion protein signature obtained from unsupervised clustering distinguished malignant from benign effusions (P = 6.18E-06). Protein subset analyses from malignant cases defined 3 cell adhesion protein clusters driven by E-cadherin, epithelial cell adhesion molecule, and N-cadherin, respectively. The components of the E- and N-cadherin clusters correlated with clinical outcome by Kaplan-Meier statistics. Univariate analysis indicated that FAK and phosphorylated AKT were associated with higher overall and progression-free survival (PFS) (P = .03), and Akt, phosphorylated paxillin, and E- and N-cadherin were associated with improved PFS (P ≤ .05). If 4 or 5 of the index adhesion proteins were high, PFS was improved by multivariate analysis (P ≤ .01). CONCLUSIONS: This hypothesis-testing examination of tumor cell adhesion molecules and pathways yielded potential predictive biomarkers with which to triage patients to selected molecular therapeutics and may serve as a platform for biomarker-based stratification for clinical application.
43
Ahmedin Jemal, Rebecca L. Siegel, Jiaquan Xu et al. · CA A Cancer Journal for Clinicians · 2010 · 12.6K citations · Full text
Disruption of epithelial cell-matrix interactions induces apoptosis
SM Frisch, H. Francis · The Journal of Cell Biology · 1994 · 3.3K citations · Full text
Andreas du Bois, Eric Pujade‐Lauraine, Philipp Harter et al. · Cancer · 2009 · 1.6K citations · Full text
A causal role for E-cadherin in the transition from adenoma to carcinoma
Anne‐Karina T. Perl, Petra Wilgenbus, Ulf Dahl et al. · Nature · 1998 · 1.4K citations